range, however CSF protein levels were noted to be raised at 1.11g/L (0.15 -0.45). Further assessment was arranged via MRI head scan. This was reported to show extensive cerebral oedema within the frontal lobes bilaterallywith evidence of highT2signal. Pachymeningeal enhancement of the frontal lobes bilaterally post-gadolineum administration, extending along the falx region towards the central sulcus was also identified. In view of her known history of sarcoidosis, a potential differential of neurosarcoidosis with recommendation of neurology team referral. Incidental finding of extensive mucosal thickening in the maxillary sinuses consistent with the patient's sinonasal disease was also identified. In view of the MRI report, Angiotensin Converting Enzyme (ACE) levels were checked and returned significantly raised at 108u/L (20-70). Prior reading taken approximately a year prior was within normal range at 52u/L (20-70). Joint neurological and rheumatological review concluded likely neurosarcoidosis. Management involved initiation of high dose steroid therapy consisting of a prednisolone dosage of 40mg once daily (calculated as approximately 0.5mg/kg). During her inpatient stay, headache symptoms improved with simple and weak opioid analgesia. No neurological or further loss of consciousness episodes occurred throughout admission. She remained stable and was discharged shortly after. Follow up shortly after in the community (approximately 1 week via phone consultation and 1 month in rheumatology clinic) demonstrated maintenance of clinical stability. Prednisolone dosage was gradually weaned over time. Repeat ACE levels taken a month following discharge returned a value within normal rangeof 33u/L (20-70). Discussion: Headaches are a common and non-specific symptom. Underlying causes are not always found and are often simply managed symptomatically. In the context of a loss of consciousness episode however, clinicians would be expected to investigate for potential pathological cause that may require intervention. In this particular case, diagnosis was largely achieved via imaging. However additional investigations such as raised ACE levels and raised CSF protein in context of the patient's backgroundof sarcoidosis,helped support the underlying diagnosis of neurosarcoidosis. Management via early high dose steroid therapy is important to help manage initial inflammation and in order to prevent further injury, and collaborative input via the neurology team can prove beneficial for specialist input ifrequiredin such cases. Key learning points: Neurosarcoidosis is a rare disorder with an estimated incidence of 5% in sarcoidosis patients. However, especially in cases of known sarcoidosis, it remains an important differential should a patient present with neurological symptoms. Definitive diagnosis is ideally via biopsy, however this may not always be possible, Use of imaging as well as markers for sarcoidosis may be beneficial in achieving diagnosis. Should neuorsarcoidosis be suspected or confirmed, then early intervention such as via prednisolone management should be initiated to settle underlying inflammation.
